LI-CYCLE HOLDINGS CORP (LICY)

CA50202P2044 - Common Stock

1.495  +0.02 (+1.01%)

Fundamental Rating

1

Overall LICY gets a fundamental rating of 1 out of 10. We evaluated LICY against 83 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of LICY have multiple concerns. LICY is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year LICY has reported negative net income.
In the past 5 years LICY always reported negative net income.
LICY had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

LICY's Return On Assets of -15.85% is on the low side compared to the rest of the industry. LICY is outperformed by 86.75% of its industry peers.
The Return On Equity of LICY (-46.73%) is worse than 81.93% of its industry peers.
Industry RankSector Rank
ROA -15.85%
ROE -46.73%
ROIC N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)-33.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LICY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

LICY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LICY has been increased compared to 1 year ago.
The debt/assets ratio for LICY has been reduced compared to a year ago.

2.2 Solvency

LICY has an Altman-Z score of -1.20. This is a bad value and indicates that LICY is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.20, LICY is not doing good in the industry: 86.75% of the companies in the same industry are doing better.
LICY has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.16, LICY is doing worse than 69.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z -1.2
ROIC/WACCN/A
WACC5.02%

2.3 Liquidity

A Current Ratio of 0.60 indicates that LICY may have some problems paying its short term obligations.
The Current ratio of LICY (0.60) is worse than 92.77% of its industry peers.
LICY has a Quick Ratio of 0.60. This is a bad value and indicates that LICY is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.54, LICY is doing worse than 92.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.54

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.64% over the past year.
LICY shows a strong growth in Revenue. In the last year, the Revenue has grown by 36.57%.
Measured over the past years, LICY shows a very strong growth in Revenue. The Revenue has been growing by 185.06% on average per year.
EPS 1Y (TTM)25.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%241.45%
Revenue 1Y (TTM)36.57%
Revenue growth 3Y185.06%
Revenue growth 5YN/A
Sales Q2Q%78.72%

3.2 Future

Based on estimates for the next years, LICY will show a very negative growth in Earnings Per Share. The EPS will decrease by -45.83% on average per year.
LICY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 107.75% yearly.
EPS Next Y-149.18%
EPS Next 2Y-72.78%
EPS Next 3Y-45.83%
EPS Next 5YN/A
Revenue Next Year93.02%
Revenue Next 2Y48.43%
Revenue Next 3Y25.14%
Revenue Next 5Y107.75%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

LICY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LICY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A cheap valuation may be justified as LICY's earnings are expected to decrease with -45.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-72.78%
EPS Next 3Y-45.83%

0

5. Dividend

5.1 Amount

LICY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LI-CYCLE HOLDINGS CORP

NYSE:LICY (12/23/2024, 12:05:30 PM)

1.495

+0.02 (+1.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners14.09%
Inst Owner Change285.71%
Ins Owners8.71%
Ins Owner Change7.88%
Market Cap34.71M
Analysts45.71
Price Target2.68 (79.26%)
Short Float %7.13%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)108.56%
Min EPS beat(2)-42.75%
Max EPS beat(2)259.87%
EPS beat(4)2
Avg EPS beat(4)3.48%
Min EPS beat(4)-468.78%
Max EPS beat(4)265.58%
EPS beat(8)3
Avg EPS beat(8)-5.11%
EPS beat(12)3
Avg EPS beat(12)-35.99%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)55.15%
Min Revenue beat(2)17.89%
Max Revenue beat(2)92.4%
Revenue beat(4)3
Avg Revenue beat(4)53.52%
Min Revenue beat(4)-29.1%
Max Revenue beat(4)132.9%
Revenue beat(8)4
Avg Revenue beat(8)15.71%
Revenue beat(12)4
Avg Revenue beat(12)-18.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5%
PT rev (3m)-28.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.15%
EPS NY rev (1m)32.92%
EPS NY rev (3m)40.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)63.08%
Revenue NY rev (1m)5.29%
Revenue NY rev (3m)4.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.9
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA N/A
EPS(TTM)-3.77
EYN/A
EPS(NY)-5.49
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.79
BVpS12.72
TBVpS12.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.85%
ROE -46.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.57%
ROA(5y)N/A
ROE(3y)-33.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.54
Altman-Z -1.2
F-ScoreN/A
WACC5.02%
ROIC/WACCN/A
Cap/Depr(3y)1835.05%
Cap/Depr(5y)1305.05%
Cap/Sales(3y)972.05%
Cap/Sales(5y)1112.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%241.45%
EPS Next Y-149.18%
EPS Next 2Y-72.78%
EPS Next 3Y-45.83%
EPS Next 5YN/A
Revenue 1Y (TTM)36.57%
Revenue growth 3Y185.06%
Revenue growth 5YN/A
Sales Q2Q%78.72%
Revenue Next Year93.02%
Revenue Next 2Y48.43%
Revenue Next 3Y25.14%
Revenue Next 5Y107.75%
EBIT growth 1Y-43.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.04%
EBIT Next 3Y18.93%
EBIT Next 5Y15.58%
FCF growth 1Y-135.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.47%
OCF growth 3YN/A
OCF growth 5YN/A